Madhusudan Natarajan

Person

Lexington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions for increasing half-life of a therapeutic agent in fel...
- Patent number 11,739,135
- Issue date Aug 29, 2023
- Invetx, Inc.
- William Brondyk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions for increasing half-life of a therapeutic agent in can...
- Patent number 11,548,949
- Issue date Jan 10, 2023
- Invetx, Inc.
- William Brondyk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions for increasing half-life of a therapeutic agent in can...
- Patent number 11,542,333
- Issue date Jan 3, 2023
- Invetx, Inc.
- William Brondyk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions for increasing half-life of a therapeutic agent in fel...
- Patent number 11,498,953
- Issue date Nov 15, 2022
- Invetx, Inc.
- William Brondyk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polypeptides with altered binding to neonatal Fc receptor (FcRn) an...
- Patent number 11,434,276
- Issue date Sep 6, 2022
- Invetx, Inc.
- William Brondyk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scler...
- Patent number 11,059,906
- Issue date Jul 13, 2021
- Takeda Pharmaceutical Company Limited
- Paolo G. V. Martini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20240327497
- Publication date Oct 3, 2024
- Invetx, Inc.
- William BRONDYK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20240239896
- Publication date Jul 18, 2024
- Invetx, Inc.
- William BRONDYK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20240239897
- Publication date Jul 18, 2024
- Invetx, Inc.
- William BRONDYK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION AND METHODS FOR THE TREATMENT OF FABRY DISEASE
- Publication number 20240175054
- Publication date May 30, 2024
- Takeda Pharmaceutical Company Limited
- Rizwana ISLAM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20240166748
- Publication date May 23, 2024
- Invetx, Inc.
- William BRONDYK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20240166749
- Publication date May 23, 2024
- Invetx, Inc.
- William BRONDYK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING COMPLEMENT FACTOR D AND USES THEROF
- Publication number 20240034779
- Publication date Feb 1, 2024
- Takeda Pharmaceutical Company Limited
- Sebastien Vallee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20230279118
- Publication date Sep 7, 2023
- Invetx, Inc.
- William BRONDYK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20230127241
- Publication date Apr 27, 2023
- Invetx, Inc.
- William BRONDYK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN FEL...
- Publication number 20230090405
- Publication date Mar 23, 2023
- Invetx, Inc.
- William BRONDYK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENO ASSOCIATED VIRAL VECTOR DELIVERY OF ANTIBODIES FOR THE TREATM...
- Publication number 20230038502
- Publication date Feb 9, 2023
- Shire Human Genetic Therapies, Inc
- Jon Kenniston
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN FEL...
- Publication number 20220259282
- Publication date Aug 18, 2022
- Invetx Inc.
- William Brondyk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN FEL...
- Publication number 20220009994
- Publication date Jan 13, 2022
- Invetx Inc.
- William Brondyk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20210347854
- Publication date Nov 11, 2021
- Invetx Inc.
- William Brondyk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20200362035
- Publication date Nov 19, 2020
- Invetx Inc.
- William Brondyk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...
- Publication number 20200216536
- Publication date Jul 9, 2020
- Invetx Inc.
- William Brondyk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-C5 ANTIBODIES WITH ENHANCED PH SWITCH
- Publication number 20190085095
- Publication date Mar 21, 2019
- Shire Human Genetic Therapies, Inc
- Madhusudan Natarajan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA
- Publication number 20180179275
- Publication date Jun 28, 2018
- Shire Human Genetic Therapies, Inc
- Paolo G.V. Martini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA
- Publication number 20160289319
- Publication date Oct 6, 2016
- Shire Human Genetic Therapies, Inc
- Paolo G.V. Martini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCL2 AND ANTI-LOXL2 COMBINATION THERAPY FOR TREATMENT OF SCLER...
- Publication number 20160083482
- Publication date Mar 24, 2016
- Shire Human Genetic Therapies Inc.
- Paolo G. V. Martini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA
- Publication number 20150158942
- Publication date Jun 11, 2015
- Shire Human Genetic Therapies, Inc
- Paolo G.V. Martini
- C07 - ORGANIC CHEMISTRY

Madhusudan Natarajan

Person

Patents Grantslast 30 patents

Compositions for increasing half-life of a therapeutic agent in fel...

Compositions for increasing half-life of a therapeutic agent in can...

Compositions for increasing half-life of a therapeutic agent in can...

Compositions for increasing half-life of a therapeutic agent in fel...

Polypeptides with altered binding to neonatal Fc receptor (FcRn) an...

Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scler...

Patents Applicationslast 30 patents

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

COMPOSITION AND METHODS FOR THE TREATMENT OF FABRY DISEASE

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

ANTIBODIES TARGETING COMPLEMENT FACTOR D AND USES THEROF

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN FEL...

ADENO ASSOCIATED VIRAL VECTOR DELIVERY OF ANTIBODIES FOR THE TREATM...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN FEL...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN FEL...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CAN...

ANTI-C5 ANTIBODIES WITH ENHANCED PH SWITCH

ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA

ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA

ANTI-CCL2 AND ANTI-LOXL2 COMBINATION THERAPY FOR TREATMENT OF SCLER...

ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA